[Therapy of urogenital tuberculosis. Urological aspects].
D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002207:Capreomycin / Q000627:therapeutic use; D003523:Cycloserine / Q000627:therapeutic use; D004357:Drug Synergism; D004724:Endoscopy; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D011859:Radiography; D012293:Rifampin / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D014401:Tuberculosis, Urogenital / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000601:surgery
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D002207:Capreomycin; D004977:Ethambutol; D003523:Cycloserine; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Zur Therapie der Urogenital-Tuberkulose. Urologische Aspekte.